Kronzer, Vanessa L. http://orcid.org/0000-0002-7489-3134
Sparks, Jeffrey A. http://orcid.org/0000-0002-5556-4618
Raychaudhuri, Soumya http://orcid.org/0000-0002-1901-8265
Cerhan, James R. http://orcid.org/0000-0002-7482-178X
Article History
Accepted: 20 February 2024
First Online: 27 March 2024
Competing interests
: J.A.S. reports consulting fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum and Pfizer. The remaining authors declare no competing interests.